Skip to content

CapEx at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$133.4M+228%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$18K+800%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$23K-73.3%
Immunome logo
ImmunomeIMNM
$3M-18.1%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$6.61M+6.4%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$390K-76.1%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's capex?
Vera Therapeutics (VERA) reported capex of $23K in Q1 2026.
How has Vera Therapeutics's capex changed year-over-year?
Vera Therapeutics's capex decreased by 87.7% year-over-year, from $187K to $23K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.